A birth control drug widely employed in Europe might additionally cure excruciating fibroids in uterus, study investigators have stated.

The research presentation was done during the twenty-sixth yearly congregation of the European Society of Human Reproduction and Embryology, Italy.

A shocking estimate provided by the non-profit National Uterine Fibroids Foundation indicates that nearly eighty percent of females suffer from fibroids in uterus (non-malignant uterine growths). These uterine fibroids could be causal to acute abdomen pains, abnormal blood loss and hamper fertility prospects among females. Surgical intervention is mostly the sole means of treating agonizing, bleeding fibroids, however surgical procedure also could at times conciliate fertility.

But, the element of a novel category of medications known as selective progesterone receptor modulators, EllaOne could play a key role in battling uterine fibroids. EllaOne is employed as an emergency contraceptive pill in Europe as it is capable of blocking outcomes of main hormones – i.e. progesterone entailed in ovulation. It is effectual for nearly 5 days following non-protected sexual intercourse. Despite not being obtainable in the United States, it has lately procured requisite votes by the FDA consultative panel for the same. A pharmaceuticals firm, HRA Pharma which offered backing for this research is also the maker of this novel medication. Progesterone hormone additionally provides nourishment to the fibroids in uterus hence obstructing its outcomes might assist in treating these agonizing growths.

Novel Medications Shrivels Uterine Fibroids

During the new-fangled study conducted on fifty-seven female entrants in the age band of 25 to fifty years of age with symptomatic fibroids, a vast proportion of females who had taken the medication of single dosage daily course for 3 period cycles exhibited abatement in uterine fibroids size in comparison to females taking the placebo tablet. Females who had taken greater dosages of the medication had a better likelihood of having considerable lowering in uterine fibroid size as compared to those who had taken lesser dosage.

The novel medication additionally aided in decreasing blood loss in comparison to the dummy set, the research found. On reaching month 3 of therapy, eighty percent of females that had taken ten milligram dosage of the novel medication and ninety-five percent of those who had taken the elevated twenty mg dosage had no period bleeding.

Researcher, Dr. Lynette Nieman from the National Inst. For Child Health and Human Development stated that the outcomes of such studies are credible and has lead them to the conclusion that EllaOne is an effectual, non-intrusive therapy for fibroids which could assist in fertility maintenance among females who sole choice left was surgical procedure.

Study investigators have also pointed out that the novel therapy additionally seems to be risk-free. Several females have been found to have a temporary noticeable rise in liver function test outcomes and some have experienced alterations in the endometrium of the uterus which have earlier been noticed with this category of medications.

Physicians hail in the novel uterine fibroid treatment

The most fascinating aspect of this novel medication is its capability of reducing heavy, erratic menses blood loss linked to fibroids alongside being able to shrivel uterine fibroid size. Till date, the sole drug which might shrivel fibroids is a medication known as Lupron that fundamentally blocks the creation of sex hormones which provide nourishment to the fibroids and leads to earlier onset menopause.

Since Lupron does come with a rather bulky cost label of menopause symptoms, it thus lowers its long-standing usefulness. Several doctors prescribe Lupron to women for fibroid management who are not willing to undergo surgery.

Hence, this novel drug is another alternative apart from Lupron for fibroid treatment without the need for surgical procedure.

Uterine fibroid embolization that fundamentally obstructs the arteries offering blood supply to the fibroid causing its shrinkage is yet another choice for treating fibroids; however it might additionally impact fertility.